Aethlon Medical Statistics
 Total Valuation
 Aethlon Medical has a market cap or net worth of $4.38 million. The enterprise value is $1.30 million.
 Important Dates
 The next estimated earnings date is Thursday, November 13, 2025, after market close.
 | Earnings Date | Nov 13, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 Aethlon Medical has 761,210 shares outstanding. The number of shares has increased by 291.97% in one year.
 | Current Share Class | 761,210 | 
| Shares Outstanding | 761,210 | 
| Shares Change (YoY) | +291.97% | 
| Shares Change (QoQ) | +14.23% | 
| Owned by Insiders (%) | 0.58% | 
| Owned by Institutions (%) | 8.54% | 
| Float | 756,817 | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | 0.44 | 
| P/TBV Ratio | 1.28 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.20.
 | Current Ratio | 2.49 | 
| Quick Ratio | 2.31 | 
| Debt / Equity | 0.20 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -842.11 | 
Financial Efficiency
 Return on equity (ROE) is -207.29% and return on invested capital (ROIC) is -77.71%.
 | Return on Equity (ROE) | -207.29% | 
| Return on Assets (ROA) | -63.64% | 
| Return on Invested Capital (ROIC) | -77.71% | 
| Return on Capital Employed (ROCE) | -231.42% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$1.40M | 
| Employee Count | 9 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
  | Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -81.08% in the last 52 weeks. The beta is 1.83, so Aethlon Medical's price volatility has been higher than the market average.
 | Beta (5Y) | 1.83 | 
| 52-Week Price Change | -81.08% | 
| 50-Day Moving Average | 8.77 | 
| 200-Day Moving Average | 24.51 | 
| Relative Strength Index (RSI) | 40.92 | 
| Average Volume (20 Days) | 68,744 | 
Short Selling Information
 The latest short interest is 133,219, so 17.50% of the outstanding shares have been sold short.
 | Short Interest | 133,219 | 
| Short Previous Month | 94,200 | 
| Short % of Shares Out | 17.50% | 
| Short % of Float | 17.60% | 
| Short Ratio (days to cover) | 0.29 | 
Income Statement
  | Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -8.51M | 
| Pretax Income | -12.58M | 
| Net Income | -12.58M | 
| EBITDA | -8.18M | 
| EBIT | -8.51M | 
| Earnings Per Share (EPS) | -$68.11 | 
 Full Income StatementBalance Sheet
 The company has $3.77 million in cash and $686,579 in debt, giving a net cash position of $3.08 million or $4.04 per share.
 | Cash & Cash Equivalents | 3.77M | 
| Total Debt | 686,579 | 
| Net Cash | 3.08M | 
| Net Cash Per Share | $4.04 | 
| Equity (Book Value) | 3.42M | 
| Book Value Per Share | 13.17 | 
| Working Capital | 2.42M | 
 Full Balance SheetCash Flow
  | Operating Cash Flow | -7.61M | 
| Capital Expenditures | n/a | 
| Free Cash Flow | -7.61M | 
| FCF Per Share | -$10.00 | 
 Full Cash Flow StatementMargins
  | Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 Aethlon Medical does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -291.97% | 
| Shareholder Yield | -291.97% | 
| Earnings Yield | -287.38% | 
| FCF Yield | -173.93% | 
 Analyst Forecast
 The average price target for Aethlon Medical is $287.50, which is 4,900.00% higher than the current price. The consensus rating is "Buy".
 | Price Target | $287.50 | 
| Price Target Difference | 4,900.00% | 
| Analyst Consensus | Buy | 
| Analyst Count | 2 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | -66.98% | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 The last stock split was on October 20, 2025. It was a reverse split with a ratio of 1:10.
 | Last Split Date | Oct 20, 2025 | 
| Split Type | Reverse | 
| Split Ratio | 1:10 | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |